Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms

[1] Fiorella D(2005)Antiplatelet therapy in neuroendovascular therapeutics Neurosurg Clin N Am 16 517-540

[2] Thiabolt L(2018)Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: A retrospective single center study of 154 consecutive patients with unruptured aneurysms Neurosurgery 44 237-241

[3] Albuquerque FC(2016)Perioperative management of dual anti-platelet therapy Hosp Pract 70 13-21

[4] Narata AP(2017)Dual antiplatelet therapy and non-cardiac surgery: Evolving issues and anesthetic implications Korean J Anesthesiol 372 196-197

[5] Amelot A(2015)Inefficacy of platelet transfusion to reverse ticagrelor N Engl J Med 18 1219-1230

[6] Bibi R(2009)Cangrelor: A novel P2Y12 receptor antagonist Expert Opin Investig Drugs 50 27-35

[7] Webster TD(2010)Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: A direct, parenteral P2Y12 receptor antagonist J Clin Pharmacol 32 1998-2004

[8] Vaishnava P(2001)Endovascular treatment of unruptured aneurysms Stroke 16 133-137

[9] Eagle KA(2010)A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents Interv Neuroradiol 37 19-24

[10] Song JW(2016)A new aneurysm occlusion classification after the impact of flow modification AJNR Am J Neuroradiol 38 310-316

[1] Fiorella D(2005)Antiplatelet therapy in neuroendovascular therapeutics Neurosurg Clin N Am 16 517-540

[2] Thiabolt L(2018)Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: A retrospective single center study of 154 consecutive patients with unruptured aneurysms Neurosurgery 44 237-241

[3] Albuquerque FC(2016)Perioperative management of dual anti-platelet therapy Hosp Pract 70 13-21

[4] Narata AP(2017)Dual antiplatelet therapy and non-cardiac surgery: Evolving issues and anesthetic implications Korean J Anesthesiol 372 196-197

[5] Amelot A(2015)Inefficacy of platelet transfusion to reverse ticagrelor N Engl J Med 18 1219-1230

[6] Bibi R(2009)Cangrelor: A novel P2Y12 receptor antagonist Expert Opin Investig Drugs 50 27-35

[7] Webster TD(2010)Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: A direct, parenteral P2Y12 receptor antagonist J Clin Pharmacol 32 1998-2004

[8] Vaishnava P(2001)Endovascular treatment of unruptured aneurysms Stroke 16 133-137

[9] Eagle KA(2010)A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents Interv Neuroradiol 37 19-24

[10] Song JW(2016)A new aneurysm occlusion classification after the impact of flow modification AJNR Am J Neuroradiol 38 310-316